2 result(s) displayed (1 - 2 of 2):

Will Senators spark FTC review of CVS Caremark? (from Corporate Dealmaker)

When CVS Corp. combined with pharmacy benefits manager Caremark Rx Inc. for $26 billion, creating CVS Caremark Corp. (NYSE:CVS) in 2007, some heads turned at the drugstore's aggressive move into PBM, where it faces possible conflicts of interest.Lately, objections to CVS' dual role as both a major seller of medicines...

Posted on July 31, 2009 2:01 PM

CVS-Caremark merger called into question (from Corporate Dealmaker)

The Federal Trade Commission was asked to re-evaluate a 2007 deal where CVS bought Caremark Rx Inc. for $26 billion to create CVS Caremark Corp. (NYSE:CVS). The National Community Pharmacists Association, with about 23,000 member pharmacies, says: "Community pharmacists have received many complaints from patients and pharmacists about CVS Caremark's...

Posted on May 14, 2009 9:01 AM